These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 14572321)

  • 1. Considerations for the development and practice of cascade impaction testing, including a mass balance failure investigation tree.
    Christopher D; Curry P; Doub B; Furnkranz K; Lavery M; Lin K; Lyapustina S; Mitchell J; Rogers B; Strickland H; Tougas T; Tsong Y; Wyka B;
    J Aerosol Med; 2003; 16(3):235-47. PubMed ID: 14572321
    [No Abstract]   [Full Text] [Related]  

  • 2. Regarding the development and practice of cascade impaction testing, including a mass balance failure investigation tree.
    Mitchell JP;
    J Aerosol Med; 2003; 16(4):433. PubMed ID: 14977433
    [No Abstract]   [Full Text] [Related]  

  • 3. Next generation pharmaceutical impactor (a new impactor for pharmaceutical inhaler testing). Part II: Archival calibration.
    Marple VA; Olson BA; Santhanakrishnan K; Mitchell JP; Murray SC; Hudson-Curtis BL
    J Aerosol Med; 2003; 16(3):301-24. PubMed ID: 14572327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cascade impactors for the size characterization of aerosols from medical inhalers: their uses and limitations.
    Mitchell JP; Nagel MW
    J Aerosol Med; 2003; 16(4):341-77. PubMed ID: 14977427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revised internal volumes of cascade impactors for those provided by mitchell and nagel.
    Copley M; Smurthwaite M; Roberts DL; Mitchell JP
    J Aerosol Med; 2005; 18(3):364-6. PubMed ID: 16181010
    [No Abstract]   [Full Text] [Related]  

  • 6. Validation of laser diffraction method as a substitute for cascade impaction in the European Project for a Nebulizer Standard.
    Vecellio None L; Grimbert D; Becquemin MH; Boissinot E; Le Pape A; Lemarié E; Diot P
    J Aerosol Med; 2001; 14(1):107-14. PubMed ID: 11495481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of tubing deposition, breathing pattern, and temperature on aerosol mass distribution measured by cascade impactor.
    Gurses BK; Smaldone GC
    J Aerosol Med; 2003; 16(4):387-94. PubMed ID: 14977429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of preseparator performance for the 8-stage nonviable andersen impactor.
    Sethuraman VV; Hickey AJ
    AAPS PharmSciTech; 2001 Mar; 2(1):E4. PubMed ID: 14727889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Particle size study of nine metered dose inhalers, and their deposition probabilities in the airways.
    Bouchikhi A; Becquemin MH; Bignon J; Roy M; Teillac A
    Eur Respir J; 1988 Jun; 1(6):547-52. PubMed ID: 3169224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the particle size characteristics of therapeutic aerosols.
    Dolovich M; Smaldone GC
    J Aerosol Med; 1999; 12(4):215-6. PubMed ID: 10724636
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro characterization of nebulizer delivery of liposomal amphotericin B aerosols.
    Alexander BD; Winkler TP; Shi S; Dodds Ashley ES; Hickey AJ
    Pharm Dev Technol; 2011; 16(6):577-82. PubMed ID: 21699390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aerosol therapy: regimen and device compliance in daily practice.
    Everard ML
    Paediatr Respir Rev; 2006; 7 Suppl 1():S80-2. PubMed ID: 16798605
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterisation of particle deposition and penetration from nasal sprays.
    Med Device Technol; 2004 Mar; 15(2):39. PubMed ID: 15154338
    [No Abstract]   [Full Text] [Related]  

  • 14. New concept for the variable flow rate Andersen cascade impactor and calibration data.
    Nichols SC; Brown DR; Smurthwaite M
    J Aerosol Med; 1998; 11 Suppl 1():S133-8. PubMed ID: 10180726
    [No Abstract]   [Full Text] [Related]  

  • 15. Optimizing nebulization practice.
    Kendrick AH; Smith EC
    Respir Med; 1996 May; 90(5):315. PubMed ID: 9499817
    [No Abstract]   [Full Text] [Related]  

  • 16. Standardization issues: in vitro assessment of nebulizer performance.
    Dennis JH
    Respir Care; 2002 Dec; 47(12):1445-55; discussion 1455-8. PubMed ID: 12467502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laser diffractometry and cascade impaction for nebulizer product characterization.
    Mitchell JP; Tservistas M
    Pharmeur Sci Notes; 2006 Dec; 2006(2):49-52. PubMed ID: 17691215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Montreal Protocol and metered dose inhalers.
    Navarro RP
    Med Interface; 1997 Apr; 10(4):135-6. PubMed ID: 10166800
    [No Abstract]   [Full Text] [Related]  

  • 19. Choosing nebulizers for children.
    Carter A
    Paediatr Nurs; 1996 Oct; 8(8):15-6. PubMed ID: 9052195
    [No Abstract]   [Full Text] [Related]  

  • 20. The U.S. Pharmacopeia's role in establishing public standards for aerosols.
    Srinivasan V
    J Aerosol Med; 1996 Mar; 9 Suppl 1():S13-7. PubMed ID: 10160053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.